Crop Production in Switzerland- Hemp/Cannabis

ByCédric Heeb
From 01.01.2021, the following applies:

  • The agricultural production of hemp is allowed, provided it isn’t classified as a narcotic. All provisions of the seed legislation relating to the production and sale of hemp seed and seedlings are repealed (set of regulations 2020).
  • For the agricultural production of hemp, the provisions of the plant health legislation and the direct payments legislation must be respected.
  • For the use of hemp as animal feed, the provisions of the animal feed legislation must be respected.
Categories of use
Category Crop THC* Use Legal base Competence
recreational Cannabis flower > 1% other than medicinal NarcA FOPH
medical Cannabis flower > 1% medicinal NarcA

TPA

 FOPH
CBD-hemp flower < 1% medicinal /

industrial

 TPA /

other

 casewise delimination
oil and fibre hemp seed, shoot < 1% industrial AgricA FOAG

*narcotic substance tetrahydrocannabinol

Information from the Federal Office of Public Health – Cannabis as narcotic

Information from the Federal Office of Public Health – Cannabis cultivation

Information from the Swiss Agency for Therapeutic Products – Questions on delimitation / Products containing cannabidiol

Information from Agroscope – Alternative crops

Information from Agroscope – Hemp as animal feed

Swiss Association for seed trade and plant breeders’ rights – Information from seed trade and distribution partners

https://www.blw.admin.ch/blw/en/home/nachhaltige-produktion/pflanzliche-produktion/hanf.html

Similar Posts

Medical cannabis for psychiatric disorders

Medical cannabis for psychiatric disorders

ByNikola NOWOTARSKA

Over last few years researchers’ attention has been focused on use of medical cannabis due to global regulatory loosening. This fact significantly increased cannabinoid therapeutics analytical data in psychiatric field. Many of them suggest that cannabinoid might improve depressive disorders and symptoms, anxiety disorders, attention-deficit hyperactivity disorder, Tourette syndrome, post-traumatic stress disorder, or psychosis. Moreover,…

Access to medicinal cannabis for patients to be simplified
|

Access to medicinal cannabis for patients to be simplified

ByCédric Heeb

Access to medicinal cannabis for patients to be simplified Bern, 22.06.2022 – The Federal Council wants to make it easier for patients to access medicinal cannabis. It therefore decided at its meeting on June 22 to lift the ban on cannabis for medicinal purposes from the Narcotics Act. Medical prescriptions no longer require an exceptional…

Cannabis – from hippie drug to medical hype (SRF, 25.04.2022)
| | | |

Cannabis – from hippie drug to medical hype (SRF, 25.04.2022)

ByCédric Heeb

The SRF documentary on Medical Cannabis provides an overview on the current market situation Key takeouts: good results on patients using the medicine high prices for patient due to 1 company dominant position flowers are not yet available as medicine (it will only be available with the #pilotprojects medical Cannabis still need to evolve from…

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process
|

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process

ByCédric Heeb

Bern, 25.08.2021 – At its meeting on August 25, 2021, the Federal Council opened the consultation on the implementation of the amendment to the Narcotics Act (BetmG) passed by Parliament. The amendment is intended to facilitate access to treatments with therapeutic cannabis. In the future, a prescription will no longer require the granting of an exceptional authorization from the Federal Office of Public Health (FOPH). Cannabis for consumption purposes, on the other hand, will continue to be prohibited.

Analysis of the publication showing that cannabinoids prevent coronavirus-2 (SARS-CoV 2) infection
|

Analysis of the publication showing that cannabinoids prevent coronavirus-2 (SARS-CoV 2) infection

ByNikola NOWOTARSKA

Content of the publication:   A new study regarding the prevention of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection responsible for COVID-19 was published on January 10, 2022, in the scientific journal “The Journal of Natural Products”[1].  Researchers from the Oregon Health and Science University in Portland (USA) have demonstrated the potential of cannabinoids to…